Children deserve simple, short, safe, and effective treatment for rifampicin-resistant tuberculosis

被引：3

作者：

Garcia-Prats, Anthony J. ^{[1
,2
]}

Hoddinott, Graeme ^{[2
]}

Howell, Pauline ^{[3
]}

Hughes, Jennifer ^{[2
]}

Jean-Philippe, Patrick ^{[4
]}

Kim, Soyeon ^{[5
]}

Palmer, Megan ^{[2
]}

Schaaf, H. Simon ^{[2
]}

Seddon, James A. ^{[2
,6
]}

Svensson, Elin ^{[7
,8
]}

Hesseling, Anneke C. ^{[2
]}

机构：

[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53705 USA

[2] Stellenbosch Univ, Fac Med & Hlth Sci, Desmond Tutu TB Ctr, Dept Paediatics & Child Hlth, Cape Town, South Africa

[3] Univ Witwatersrand, Sizwe Trop Dis Hosp, Dept Internal Med, Clin HIV Res Unit,Wits Hlth Consortium, Johannesburg, South Africa

[4] NIAID, NIH, Bethesda, MD USA

[5] Frontier Sci Fdn, Dept Biostat, Brookline, MA USA

[6] Imperial Coll London, Dept Infect Dis, London, England

[7] Uppsala Univ, Dept Pharm, Uppsala, Sweden

[8] Radboud Univ Nijmegen, Med Ctr, Res Inst Med Innovat, Dept Pharm, Nijmegen, Netherlands

来源：

LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 07期

基金：

美国国家卫生研究院;

关键词：

PRETOMANID;

D O I：

10.1016/S1473-3099(23)00349-3

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页数：3

共 50 条

[21] Evaluation of miLINC to shorten time to treatment for rifampicin-resistant Mycobacterium tuberculosis
Farley, J. E.
McKenzie-White, J.
Bollinger, R.
Hong, H.
Lowensen, K.
Chang, L. W.
Stamper, P.
Berrie, L.
Olsen, F.
Isherwood, L.
Ndjeka, N.
Stevens, W.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (09) : 980 - +
[22] The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis
Whitfield, Michael G.
Warren, Robin M.
Mathys, Vanessa
Scott, Lesley
De Vos, Elise
Stevens, Wendy
Streicher, Elizabeth M.
Groenen, Guido
Sirgel, Frederick A.
Van Rie, Annelies
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (10) : 2667 - 2674
[23] Rifampicin-resistant Tuberculosis: A Global Health Dilemma
Ahmad, Rahnuma
Sinha, Susmita
Chowdhury, Kona
Haque, Mainul
ADVANCES IN HUMAN BIOLOGY, 2024, 14 (02) : 87 - 91
[24] Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap Reply
Stagg, Helen R.
Harris, Ross J.
Lipman, Marc C.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (10) : 1419 - 1419
[25] Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
Zehua Zhang
Fei Dai
Fei Luo
Min Zhong
Zhenggu Huang
Tianyong Hou
Jianzhong Xu
Journal of Orthopaedic Surgery and Research, 9
[26] Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
Zhang, Zehua
Dai, Fei
Luo, Fei
Zhong, Min
Huang, Zhenggu
Hou, Tianyong
Xu, Jianzhong
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2014, 9 : 124
[27] Hepatocellular Injury in Children Treated for Rifampicin-resistant Tuberculosis: Incidence, Etiology and Outcome
Duvenhage, Joanie
Draper, Heather R.
Garcia-Prats, Anthony J.
Winckler, Jana
Hesseling, Anneke C.
Schaaf, H. Simon
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (12) : 953 - 958
[28] Isoniazid/rifampicin/pyrazinamide/ethambutolDevelopment of rifampicin-resistant tuberculosis: case report
Reactions Weekly, 2015, 1573 (1) : 144 - 144
[29] Rifampicin-induced transcriptome response in rifampicin-resistant Mycobacterium tuberculosis
de Knegt, Gerjo J.
Bruning, Oskar
ten Kate, Marian T.
de Jong, Mark
van Belkum, Alex
Endtz, Hubert P.
Breit, Timo M.
Bakker-Woudenberg, Irma A. J. M.
de Steenwinkel, Jurriaan E. M.
TUBERCULOSIS, 2013, 93 (01) : 96 - 101
[30] Barriers and solutions to finding rifampicin-resistant tuberculosis cases in older children and adolescents
Mohr-Holland, E.
Apolisi, I
Reuter, A.
de Azevedo, V
Hill, J.
Matthee, S.
Seddon, J. A.
Isaakidis, P.
Furin, J.
Trivino-Duran, L.
PUBLIC HEALTH ACTION, 2019, 9 (04): : 174 - 176

← 1 2 3 4 5 →